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Introduction
The seven subunit actin-related protein (Arp) 2/3 complex 
nucleates actin filaments that drive diverse cell processes such 
as vesicle trafficking, plasma membrane protrusion during cell 
migration, and motility of some pathogens in host cells (Goley 
and Welch, 2006). Hence, resolving how activity of the Arp2/3 
complex is regulated is important for a basic understanding 
of diverse cell processes and for targeting aberrant actin- 
dependent cell behaviors in diseases. Arp2/3 complex binding 
to nucleation promoting factors (NPFs) such as N-WASP was 
previously thought to be sufficient to increase nucleating activity 
(Welch and Mullins, 2002). However, we recently showed that 
the Arp2 subunit must be phosphorylated for the complex to be 
activated by NPFs (LeClaire et al., 2008; Narayanan et al., 2011; 
Choi et al., 2013). The necessary role for Arp2 phosphorylation 
for nucleation activity suggests that the Arp2/3 complex is a 
coincidence detector requiring both binding to NPFs and phos-
phorylation of Arp2 for increased activity. Coincidence detec-
tion is emerging as a common regulatory mechanism for many 
actin-binding proteins, including NPFs (Rohatgi et al., 2001; 
Rivera et al., 2009) and cofilin (Frantz et al., 2008; Magalhaes 
et al., 2011). In support of coincidence regulation of the Arp2/3 
complex, we show that expression of a phosphorylation- 
defective Arp2 mutant complexes with endogenous Arp2/3 com-
plex subunits and dominantly suppresses increased actin filament 
assembly and membrane protrusion in response to EGF.
Despite the confirmed importance of phosphorylated Arp2 
in the nucleation activity of the Arp2/3 complex, kinases phos-
phorylating Arp2 have not been identified. We report that the 
Nck-interacting kinase (NIK), a Ste20/MAP4K4 serine/threonine 
kinase, phosphorylates Arp2 and primes the Arp2/3 complex 
for activation by NPFs. NIK and its orthologues have a con-
served role in regulating actin cytoskeleton-dependent cell pro-
cesses. NIK activity is necessary for mesoderm migration 
(Xue et al., 2001) and for epithelial cell membrane protrusion 
(Baumgartner et al., 2006) and invasion (Wright et al., 2003). 
The NIK orthologue misshapen in Drosophila melanogaster 
functions in determining epithelial polarity, neuronal targeting, 
and cell invasion (Su et al., 1997; Cobreros-Reguera et al., 
2010), and the orthologue MIG-15 in Caenorhabditis elegans 
controls axonal navigation (Poinat et al., 2002) and neuroblast 
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5 min (Fig. 1 D). At all time points with EGF, F-actin abundance 
was not different with expression of Arp2-WT compared with 
WT cells but was significantly less with expression of Arp2-
TTY/A and with latrunculin B (1 µM), which binds and seques-
ters G-actin (Fig. 1 D). In the absence of EGF, the mean F-actin 
abundance was not different with Arp2-TTY/A or latrunculin 
compared with WT cells.
Compared with WT cells and Arp2-WT, expression of 
Arp2-TTY/A decreased the extent and rate of membrane pro-
trusions with EGF. In growth medium, there were no obvious 
morphological differences between WT cells and cells express-
ing Arp2-WT or Arp2-TTY/A, as indicated in Fig. 1 C. How-
ever, marked differences were seen with Arp2-TTY/A in 
quiescent cells, as indicated in cells expressing the actin fila-
ment reporter Lifeact-GFP (Riedl et al., 2008). Images captured 
by time-lapse microscopy showed that quiescent WT and Arp2-
WT cells had marked cortical actin bundles and a ruffled plasma 
membrane. With EGF, the cortical actin bundle remained mostly 
unchanged but lamellipodia rapidly extended (Fig. 2 A). Quies-
cent cells expressing Arp2-TTY/A mostly lacked a distinct 
cortical actin bundle and had fewer and smaller ruffles but an 
increase in filopodia containing actin filaments in linear arrays 
(Fig. 2 A). With EGF, extension of lamellipodia was markedly 
reduced but there was little change in the number or length of 
filopodia. We also saw this stellate phenotype with filopodia in 
MTLn3 cells treated with CK666 (Fig. 2 A), and, as we previ-
ously reported, in Drosophila S2 cells with RNAi knockdown 
of Arp2 and expression of Arp2-T237/238A-Y202A (LeClaire 
et al., 2008). Additionally, the stellate phenotype is seen in fi-
broblasts lacking ARPC2 (Wu et al., 2012) or ARPC3 (Suraneni 
et al., 2012) subunits. Hence, inhibiting the Arp2/3 complex 
may unmask actin assemblies regulated by other nucleators 
such as formins, which can generate contractile actin filaments. 
Consistent with this prediction, cells with Arp2-TTY/A and 
CK666 were smaller and appeared more contracted. Additional 
analysis showed that an increase in the area of WT and Arp2-WT 
cells with EGF was significantly less with Arp2-TTY/A and 
CK666 (Fig. 2 B). Compared with WT cells, the rate of mem-
brane protrusion was significantly faster, with Arp2-WT at 
2 and 3 min and significantly slower with Arp2-TTY/A at 3, 4, 
and 5 min (Fig. 2 C). It is unclear why the phenotype of cells 
expressing Arp2-TTY/A is different with quiescence compared 
with being maintained in growth medium but may reflect an 
unresolved role for Arp2 phosphorylation. Although cells ex-
pressing Arp2-TTY/A had a slower proliferation rate than WT 
and Arp2-WT cells (Fig. S1), they were viable, which is in con-
trast to the lethality of Dictyostelium discoideum cells lacking 
this subunit (Zaki et al., 2007). The ability of Arp2-TTY/A to 
assemble with endogenous Arp2/3 complex subunits and sup-
press EGF-induced actin filament assembly and membrane pro-
trusion without disrupting localization of the complex suggests 
a new strategy to determine functions of the Arp2/3 complex in 
diverse cell processes.
The Arp2/3 complex is an NIK substrate
To identify kinases that phosphorylate Arp2, we used in vitro ki-
nase assays with Arp2/3 complex purified from Acanthamoeba 
migration (Chapman et al., 2008). However, a substrate for 
NIK or an orthologue that directly regulates actin filament as-
sembly has not been identified. We show that NIK activity is 
necessary for increased Arp2 phosphorylation and membrane 
protrusion in response to EGF and also that NIK directly binds 
the Arp2/3 complex. These findings identify a new regulator 
for increasing Arp2/3 complex activity and suggest that NIK 
phosphorylation of Arp2 is a mechanism linking growth factor 
signaling to actin filament assembly.
Results and discussion
Arp2-T237/238A-Y202A dominantly 
suppresses EGF-increased actin filament 
assembly and membrane protrusion
Previous studies to reveal cell processes regulated by Arp2/3 
complex have mostly used RNA interference or genetic deple-
tion to eliminate expression of individual subunits (Di Nardo 
et al., 2005; Nicholson-Dykstra and Higgs, 2008; Suraneni 
et al., 2012; Wu et al., 2012). However, a limitation of these 
approaches is that expression of other subunits is abolished 
because subunit stability depends on an assembled complex. 
Small molecule inhibitors of Arp2/3 complex activity (Nolen 
et al., 2009) retain an intact complex but disrupt cortical local-
ization of the complex (Yang et al., 2012). We asked whether 
these limitations could be resolved by heterologous expression 
of a mutant nonphosphorylatable Arp2 to dominantly inhibit 
endogenous Arp2/3 complex activity.
To test this prediction, we stably expressed Arp2 wild 
type (WT) and a T237/238A-Y202A mutant (TTY/A), tagged 
at the C terminus with tandem HA and V5 epitopes, in MTLn3 
rat carcinoma cells. We used the triple phospho-site Arp2 mu-
tant because we previously showed that phosphorylation of 
either Thr237/238 or Tyr202 functions as an OR gate for NPF-
stimulated Arp2/3 complex activity (LeClaire et al., 2008; Choi 
et al., 2013). Immunoblotting cell lysates with antibodies to 
V5 showed similar expression levels of recombinant Arp2-WT 
and -TTY/A, and neither construct changed the abundance of 
endogenous ARPC1, ARPC2, or Arp2 (Fig. 1 A). ARPC1 
coprecipitated with HA-immune complexes of Arp2-WT 
and -TTY/A (Fig. 1 B), which suggests that recombinant Arp2 
assembles with endogenous Arp2/3 complex subunits.
In MTLn3 cells maintained in growth medium, HA immuno-
labeling was seen at the distal margin of cells expressing Arp2- 
WT and -TTY/A but was not in vector control cells, although 
all cells showed a nonspecific cytoplasmic signal (Fig. 1 C). 
Co-labeling for endogenous ARPC1 showed localization at 
the cell distal margin and overlap with HA labeling of both 
Arp2-WT and -TTY/A in merged images (Fig. 1 C), which 
indicates that localization of the Arp2/3 complex is not dis-
rupted by expression of Arp2-TTY/A.
Expression of Arp2-TTY/A dominantly suppressed in-
creased actin filament assembly with EGF. In MTLn3 cells, 
EGF induces a marked increase in F-actin (Chan et al., 1998; 
Yang et al., 2012), which we confirmed by measuring fluorescence 
of fixed cells labeled with rhodamine phalloidin. In WT cells, 
a time-dependent increase in F-actin with EGF was maximal at 
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data). Src phosphorylated Arp3 and Arp2 subunits (Fig. S2 A), 
but as described below it had no effect on nucleating activity. In 
contrast, NIK phosphorylated Arp3, Arp2, and ARPC2 subunits 
of the A. castellanii Arp2/3 complex and recombinant human 
Arp2/3 complex generated by baculovirus expression (Fig. 3 A). 
NIK also phosphorylated the ARPC5 subunit of human but not 
A. castellanii Arp2/3 complex. Phosphorylation of subunits was not 
detected in the absence of NIK or with a mutant kinase-inactive 
castellanii and dephosphorylated with Antarctic phosphatase 
(AP). We tested a subset of kinases previously shown to asso-
ciate with the Arp2/3 complex or regulate actin or membrane 
dynamics, including p21-activated kinase (PAK), the Src tyro-
sine kinase (Src), focal adhesion kinase (FAK), and NIK. Neither 
PAK1, a Ste20 family member like NIK, nor FAK phosphory-
lated any Arp2/3 complex subunit, although they did phosphory-
late the generic substrate myelin basic protein (unpublished 
Figure 1. Arp2-T237/238A-Y202A coprecipitates with endogenous Arp2/3 complex subunits and dominantly suppresses EGF-increased actin filament 
assembly. (A) Immunoblot of lysates from WT MTLn3 cells (WT) and MTLn3 cells stably expressing recombinant Arp2 WT (Arp2-WT) and mutant T237/
238A-Y202A (Arp2-TTY/A) tagged with VA and HA epitopes show that expression of recombinant Arp2 does not change the abundance of endogenous 
ARPC1, ARPC2, or Arp2. (B) Immunoblot of proteins in anti-HA immune complexes shows coprecipitation of endogenous ARPC1 with recombinant Arp2 
WT and mutant TTY/A. (C) Immunolabeling with anti-HA and anti-ARPC1 antibodies indicates colocalization at the distal margin of plasma membrane 
protrusions. Bar, 5 µm. (D) Total F-actin in MTLn3 cells in the absence and presence of EGF for the indicated times shows a similar time-dependent increase 
in WT cells and cells expressing Arp2-WT that is significantly attenuated in cells expressing Arp2-TTY/A or WT cells treated with latrunculin. Data 
are means ± SEM (error bars) of triplicate determinations in four separate cell preparations. *, P < 0.05; **, P < 0.01; ***, P < 0.001 compared with 
WT at the same time point (Student’s t test).
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effect on the stoichiometric assembly of rArp2/3 complex 
subunits (Fig. 3 B, gel). Active NIK but not NIK-D152N 
phosphorylated Arp3, Arp2, and ARPC2 subunits of WT 
rArp2/3 complex (Fig. 3 B). With mutant Arp2-T237/238A-
Y202A, NIK phosphorylation of Arp2 was abolished but 
phosphorylation of Arp3 and ARPC2 was unchanged com-
pared with WT. Kinetic analysis revealed a Km of 37.7 ± 8 µM 
NIK (NIK-D152N) that lacks ATP binding but retains substrate 
binding (Baumgartner et al., 2006; Fig. 3 A).
To test whether NIK, a Ser/Thr kinase, phosphorylates 
Arp2-Thr237/238, we used as a substrate recombinant Arp2/3 
(rArp2/3) complex containing Arp2-WT or -TTY/A, gener-
ated by baculovirus expression as we described previously 
(Narayanan et al., 2011). Recombinant Arp2-TTY/A had no 
Figure 2. Expression of recombinant Arp2-TTY/A inhibits membrane protrusion with EGF. (A) Time-lapse images of MTLn3 cells expressing Lifeact-GFP 
in the absence (0 min) and presence (5 min) of EGF show differences in morphology and changes in plasma membrane protrusions for WT, Arp2-WT, 
Arp2-TTY/A, and WT cells treated with the Arp2/3 inhibitor CK666. Cells expressing Arp2-TTY/A or treated with CK666 had prominent filopodia in 
the absence of EGF that did not increase in size or abundance with EGF. Also shown are overlapped tracings of the cell periphery in the absence (red 
and green outlines) and presence of EGF (yellow and blue outlines) that were used to quantify cell area, as well as high-magnification images of the cell 
periphery at 5 min with EGF (shown on the right, taken from the indicated cyan boxes). Bars: (left) 5 µm; (right) 2 µm. (B) WT and Arp2-WT cells had 
increased areas after 5 min with EGF that was significantly less with Arp2-TTY/A and WT cells treated with the Arp2/3 complex inhibitor CK666. Data 
are from four separate cell preparations, with each filled circle representing a single cell (for WT, n = 39; for Arp2-WT, n = 34; for Arp2-TTY, n = 36; 
for CK666, n = 14). (C) The rate of membrane protrusion was significantly faster with Arp2-WT at 2 and 3 min and significantly slower with Arp2-TTY/A 
at 3, 4, and 5 min compared with WT cells. *, P < 0.05; **, P < 0.01; ***, P < 0.001 compared with WT (Student’s unpaired t test).
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the motif KRRX (Fig. 3 D). These regions are similar to those 
found in ActA, WASP, N-WASP, and Scar that are necessary 
to bind the complex (Marchand et al., 2001). When transiently 
expressed in MTLn3 cells, Myc-tagged NIK-D152N but not 
WT NIK coprecipitated endogenous Arp2 (Fig. 3 E), which 
suggests binding in cells and also that with phosphorylation 
by WT NIK, the Arp2/3 complex may undergo conformational 
changes that disrupt binding in cells.
NIK-phosphorylated Arp2/3 complex has 
increased nucleating activity
Based on computational modeling and in vitro studies with 
rArp2/3 complex, we previously proposed a model predicting 
that phosphorylation of Arp2 Thr236/237 disrupts an elec-
trostatic interaction with ARPC4 Arg104/105 to relieve an 
autoinhibited Arp2/3 complex and allow activation by NPFs 
(Narayanan et al., 2011). Consistent with this model, full-
length WT NIK but not NIK-D152N restored the actin nucle-
ation activity of Arp2/3 complex dephosphorylated with AP 
to 80% of the Arp2/3 complex rate without AP treatment 
(Fig. 4 A). The time to half maximal actin polymerization (T1/2) 
of AP-treated Arp2/3 complex was reduced from 900 s to <400 s 
with NIK (Fig. S3). The NIK kinase domain (NIK 1–288) lacking 
for total phosphorylation of the Arp2/3 complex by NIK 
(Fig. S2 C). These data confirm Thr237 and Thr238 as the 
Arp2 residues phosphorylated by NIK in vitro. The signifi-
cance of NIK-phosphorylated residues in Arp3 and ARPC2 
is unknown; however, as described below, NIK-dependent 
phosphorylation of Arp2 but not Arp3 or ARPC2 was seen in 
cells (see Fig. 5).
The C-terminal regulatory domain of NIK directly binds 
substrates, including the mitogen-activated protein kinase kinase 
MEKK1, within residues 906–1,233 (Su et al., 1997), the ERM 
proteins ezrin, radixin, and moesin within 288–321 (Baumgartner 
et al., 2006), and the Na-H exchanger NHE1 within 407–520 
(Yan et al., 2001). Arp2/3 complex immobilized on CH- 
Sepharose bound in vitro–translated NIK 1–500 and NIK 1–703 
but not NIK 1–340 (Fig. 3 C), which suggests that there is an 
Arp2/3 complex binding region within amino acids 340–500 
that overlaps with the NHE1-binding region. A. castellanii 
Arp2/3 complex coprecipitated with GST-NIK 340–500 with 
an apparent Kd 0.213 µM (Fig. S2 D), which is similar to 
high-affinity binding by other Arp2/3-binding proteins, includ-
ing Scar (Pan et al., 2004; LeClaire et al., 2008) and N-WASP 
(Kelly et al., 2006; LeClaire et al., 2008). The Arp2/3 complex 
binding region in NIK includes multiple polybasic regions with 
Figure 3. NIK phosphorylates and binds the Arp2/3 complex. (A) In vitro, WT NIK but not kinase-inactive NIK-D152N phosphorylates Arp3, Arp2, and 
ARPC1 subunits of the Arp2/3 complex purified from A. castellanii and from baculovirus expression of human recombinant Arp2/3 complex (rArp2/3). 
(B) NIK phosphorylation of Arp2 but not Arp3 and ARPC3 subunits is not seen with rArp2/3 complex containing a mutant Arp2-T237/238A-Y202A. 
(C) Arp2/3 complex coupled to CH-Sepharose and incubated with recombinant NIK 1–340, NIK 1–500, and NIK 1–703 shows that the NIK region of 
amino acids 340–500 binds the Arp2/3 complex. (D) Schematic of NIK showing the kinase domain and proposed Arp2/3 complex binding domain, 
which contains abundant acidic (red) and basic (blue) residues. (E) Arp2 coprecipitates in Myc immune complexes of MTLn3 cells transiently expressing 
Myc-tagged NIK-D152N by not with Myc-tagged WT NIK or empty adenovirus (Ad).
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NIK activity is necessary for EGF-increased 
Arp2 phosphorylation and  
membrane protrusion
Arp2 phosphorylation increases in MTLn3 mammary car-
cinoma cells treated with EGF (LeClaire et al., 2008) and in 
D. discoideum cells treated with cAMP (Choi et al., 2013); 
however, a kinase mediating either effect has not been iden-
tified. To test a possible role for NIK, we used metabolically 
labeled MTLn3 cells stably expressing shRNA for NIK or 
a nontargeting (NT) shRNA, confirming the specificity of de-
creased NIK expression by immunoblotting (Fig. 5 A). Incorpo-
ration of [32P]orthophosphate into Arp2/3 complex subunits was 
determined in immune complexes obtained using ARPC1 sub-
unit antibodies. Quiescent control and NT cells had a low basal 
level of phosphorylated Arp2 that was markedly increased with 
EGF by 60 s (Fig. 5 A). A second phosphorylated polypeptide 
the Arp2/3 complex binding site increased Arp2/3 activity to 
30% of untreated Arp2/3 complex, which suggests that NIK-
increased nucleating activity is in part dependent on binding the 
Arp2/3 complex (Fig. 4 B). However, NIK 340–500 had no ef-
fect on the nucleating activity of untreated or AP-treated Arp2/3 
complex (Fig. 4 B), which indicates that the binding domain 
without the kinase domain is not sufficient to activate the com-
plex. Additionally, rArp2/3 with Arp2-TTY/A was inactive in the 
presence of Scar-VCA both with and without NIK (Fig. 4 C), 
further confirming that the Arp2 phosphorylation sites T237/238-
Y202 are necessary for NIK-increased Arp2/3 complex nucleat-
ing activity. Although Src phosphorylated several Arp2/3 complex 
subunits (Fig. S1 A), it did not restore the nucleation activity of 
the AP-Arp2/3 complex (Fig. 4 D). The functional significance 
of Src-increased phosphorylation and whether Src phosphory-
lates Arp2-Y202 remain to be determined.
Figure 4. NIK restores the actin nucleation activity of the Arp2/3 complex. (A) Pyrene actin assays show that WT NIK but not kinase-inactive NIK-D152N 
restores activity of alkaline phosphatase–treated Arp2/3 complex with but not without the VCA domain of Scar. (B) The NIK kinase domain (NIK 1–288) 
lacking Arp2/3 complex binding sites activates Arp2/3 complex to 30% of the rate of Arp2/3 complex phosphorylated by full-length NIK. The NIK 
Arp2/3 binding domain (NIK 340–500) lacking the kinase domain has no effect on Arp2/3 complex activity. (C) Actin-nucleation activity of Arp2/3 
complex containing T237/238A-Y202A Arp2 is not restored with NIK. (D) Src does not restore activity of dephosphorylated Arp2/3 complex. The data 
shown for pyrene actin traces are from a single representative experiment out of three repeats.
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Consistent with NIK increasing phosphorylation and activity 
of the Arp2/3 complex in vitro, the EGF-induced increase in 
MTLn3 cell area seen in controls was significantly attenuated 
with expression of NIK-D152N-GFP and NIK shRNA (Fig. 5, 
D and C; and Fig. S3 B). Additionally, the rate of membrane 
protrusion with EGF was significantly less with NIK shRNA com-
pared with NT shRNA (Fig. 5 F). We previously showed that 
NIK-dependent membrane protrusion with EGF is in part de-
pendent on NIK phosphorylation of ERM proteins (Baumgartner 
et al., 2006). The ERM protein ezrin stabilizes membrane blebs 
migrating at 45 kD did not correspond to Arp2/3 complex 
subunits and was not identified. Phosphorylation of Arp3 and 
ARPC2, subunits that NIK phosphorylated in vitro (Fig. 3 A), 
was not detected in cells. Cells expressing NIK shRNA had 
lower basal phosphorylation of Arp2 that did not increase with 
EGF (Fig. 5 A). Arp2 phosphorylation with EGF was also mark-
edly less in MTLn3 cells infected with adenovirus expressing 
kinase-inactive NIK-D152N-GFP compared with adenovirus 
controls (Fig. 5, B and C), which suggests the significance of 
NIK activity and not just NIK binding.
Figure 5. NIK activity is necessary for increased Arp2 phosphorylation with EGF in MTLn3 cells. (A) The Arp2/3 complex was immunoprecipitated from 
32P-labeled MTLn3 cells stimulated with EGF. Increased Arp2 phosphorylation with EGF for 60 s in ARPC1 immune complexes from WT MTLn3 cells and 
with nontargeting shRNA (NT shRNA) was not seen in cells expressing NIK shRNA. Top, autorad indicating 32P incorporation; bottom, immunoblot for 
Arp2. (B) Phosphorylation of Arp2, determined as in A, increased in cells infected with control Ad-NIK WT but not with Ad-NIK-D152N-GFP. (C) Arp2 
phosphorylation after EGF stimulation increased approximately twofold more in cells expressing NIK WT compared with NIK D152N (error bars indicate 
SD). (D and E) In response to EGF, the fold increase in cell area with Ad-GFP and NT-shRNA was significantly less with Ad-NIK-D152N-GFP and NIK 
shRNA. (F) Rates of membrane protrusion with EGF were significantly less with NIK shRNA compared with NT shRNA. Data represent means of values from 
25–50 cells in three to four separate cell preparations. **, P < 0.01; ***, P < 0.001 (Student’s t test).
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0.1% Triton X-100. After washing and blocking for 30 min with 10% FCS 
in PBS, samples were incubated for 1 h with mouse monoclonal anti-HA 
and rabbit polyclonal-ARPC1 antibodies, washed, and incubated with 
Alexa Fluor 488– and 548–conjugated secondary antibodies (The Jackson 
Laboratory). Cells mounted in fluorescence were viewed by using a 
microscope system (Nikon) with a CSU-10 spinning disk confocal head 
(Yokogawa Electric Corporation) with a 60× Plan-Apochromat TIRF/1.45 
NA oil immersion objective lens at 25°C. Images were collected with a 
charge-coupled device (CCD) camera (HQ2; Photometrics) and viewed 
with Elements software (Nikon).
For immunoprecipitation, cells were lysed with modified RIPA buffer 
(50 mM Tris, pH 7.5, 100 mM NaCl, 10% glycerol, 1% NP-40, 1 mg/ml 
aprotinin, 1 mM pefabloc, and 1 mg/ml leupeptin) containing phosphatase 
inhibitors (1 mM EGTA, 50 mM NaF, 10 mM sodium pyrophosphate, 1 mM 
-glycerophosphate, and 1 mM sodium orthovanadate). For Arp2 phosphory-
lation, before lysis cells were metabolically labeled by incubating for 4 h in 
phosphate-free MEM supplemented with 0.2 mCi/ml [32P]orthophosphate. 
After preclearing and blocking for 1 h with protein A, lysates were incu-
bated with mouse monoclonal HA or rabbit polyclonal ARPC1 antibodies 
bound to protein A–conjugated Dynabeads (Life Technologies) for 20 h at 
4°C. Beads were washed three times with modified RIPA, resuspended in 
1× Laemmli sample buffer, and immune complexes separated by SDS-PAGE 
followed by either immunoblotting or autoradiography.
Coimmunoprecipitation was performed by infecting MTLn3 cells with 
adenovirus containing either WT NIK-Myc, kinase inactive NIK (D152N-
Myc), or empty vector (Ad) for 48 h. Cell lysates were prepared as de-
scribed above, precleared with protein G Sepharose, and incubated for 2 h 
with 3 µg Myc mouse monoclonal antibody (EMD Millipore) at 4°C. Immune 
complexes were precipitated with protein G for 30 min, separated by SDS-
PAGE, transferred to PVDF, and probed with antibodies to Myc and Arp2. 
Cell lysates were probed with antibodies to GAPDH (EMD Millipore).
Actin polymerization
Cellular F-actin in the absence and presence of EGF was determined in 
MTLn3 cells plated in 24-well dishes. Latrunculin B (Life Technologies) was 
added 15 min before EGF treatment. At the indicated times, cells were fixed 
as described above for immunolabeling and incubated with rhodamine-
phalloidin (1:500; Life Technologies) for 30 min. After washing, cells were 
incubated for 5 min with Hoechst 33342 (1:10,000; Life Technologies) to 
label nuclei. Labeling was measured with a SpectraMax M5 plate reader 
(Molecular Devices), with rhodamine fluorescence normalized to Hoerchst 
signal and data expressed relative to WT cells in the absence of EGF.
In vitro actin polymerization was measured using 4 µM monomeric 
nonmuscle actin containing 5% pyrene-labeled actin in KMEI (50 mM KCl, 
1 mM MgCl2, 1 mM EGTA, and 10 mM imidazole, pH 7.0; LeClaire et. al 
2008). Polymerization was determined in the absence or presence of 5 nM 
rArp2/3 complex, 500 nM of VCA domain of Scar, and recombinant WT 
or mutant NIK. Pyrene actin was excited in a spectrophotometer (RF-5301PC; 
Shimadzu) at 365 nm, and fluorescence was measured at 407 nm at 1-s in-
tervals. Purified rArp2/3 complex was dephosphorylated by treatment with 
1 U AP (New England Biolabs, Inc.) in Tris-HipH buffer (50 mM Tris, pH 8.0, 
1 mM Mg2Cl2, and 0.1 mM ZnCl2) for 1.5 h at 30°C.
Cell proliferation
MTLn3 cells maintained in growth medium were counted 48 h after plating 
10 × 105 cells/well in 24-well plates. Doubling time was determined and 
data are shown for individual wells from four separate cell plating prepara-
tions. Significant differences compared with WT MTLn3 cells were deter-
mined with an unpaired t test.
Video microscopy
MTLn3 cells plated in MatTek 35-mm glass-bottom dishes (MatTek Corpora-
tion) were imaged using the microscope system described above in a 
climate-regulated chamber at 37°C and 5% CO2. Changes in cell area 
were measured as described previously (El-Sibai et al., 2008), with the fol-
lowing modifications to quantify changes in cell size after stimulation with 
growth factors. Images of cells were captured at 20-s intervals, beginning 
2 min before adding 5 nM EGF and ending 10 min after adding EGF. 
Image analysis was performed in NIS Elements software (Nikon), including 
time-dependent changes in cell size and lamellipodium, designated as the 
region from the cell body to the distal margin of the plasma membrane. Fold 
increase in cell (C) area was calculated by the equation C = AEGF/AQ, 
where AEGF is the area of the lamellipodium measured 5 min after EGF 
stimulation and AQ is the area of the lamellipodium measured before EGF 
stimulation. Approximately 30 cells were measured for each condition.
by tethering cortical actin filaments to the plasma membrane 
(Charras et al., 2006). Hence, we propose that in response to EGF, 
NIK activates the Arp2/3 complex to initiate membrane protru-
sions, which are stabilized by NIK activation of ERM proteins.
Our findings identify NIK as the first kinase shown to both 
phosphorylate Arp2/3 complex subunits and increase nucleation 
activity. Of particular interest is that in addition to NIK binding 
the Arp2/3 complex, it also binds and phosphorylates ERM pro-
teins (Baumgartner et al., 2006) and NHE1 (Yan et al., 2001), 
which also regulate actin dynamics at the plasma membrane 
(Denker and Barber, 2002; Patel and Barber, 2005; Frantz et al., 
2008; Neisch and Fehon, 2011). As its acronym indicates, NIK 
binds the receptor tyrosine kinase adaptor protein Nck, and Nck 
binds to and activates N-WASP (Rohatgi et al., 2001; Rivera 
et al., 2009). Together, these findings suggest that NIK coordi-
nates actin filament and membrane dynamics in response to ac-
tivated receptor tyrosine kinases.
Materials and methods
MTLn3 cell culture and infection
MTLn3 rat adenocarcinoma cells (provided by J. Condeelis, Albert Einstein 
College of Medicine, New York, NY) were maintained in MEM without 
nucleosides supplemented with 10% FBS at 37°C and 5% CO2. Cells were 
made quiescent by decreasing FBS medium from 10% to 0.2% for 4 h. For 
expression of recombinant Arp2, cells were infected with lentivirus express-
ing WT Arp2 and Arp2-T237/238A-Y202A tagged at the C terminus with 
tandem HA and V5 epitopes. Expression was selected by resistance to blas-
ticidin and confirmed by immunoblotting and immunolabeling. NT and NIK 
shRNA were obtained from SABiosciences with the sequence 5-CTC-
GGGAGGTGGAAGATAGATTT-3 to silence NIK expression. Plasmids were 
transfected into cells with a 5:2 ratio of Fugene HD (Promega) with a 2 µg 
shRNA construct. Cells positive for GFP expression were isolated by flow cy-
tometry after 48 h and cultured for an additional 48 h before analysis. The 
plasmid containing mEGFP-N1-LifeAct was provided by R. Wedlich-Sölder 
(Max Planck Institute of Biochemistry, Martinsried, Germany). The EGFP-N1 
LifeAct sequence was cloned into a pENTR TOPO plasmid (Life Technolo-
gies) and recombined into pLenti 6.1 destination vector using Gateway clon-
ing technology (Life Technologies). Lentiviruses were produced and packaged 
in HEK293TA cells using the ViraPower Lentiviral Packaging kit (Life Technol-
ogies) according to the manufacturer’s instructions (Haynes et al., 2011). For 
lentiviral transduction, MTLn3 cells were infected in growth medium supple-
mented with 4 µg/ml Polybrene (Sigma-Aldrich). Infected cells were selected 
with 15 µg/ml blasticidin (Life Technologies). Adenovirus was prepared by 
cloning WT NIK and D152N NIK into pAD-TRACK-CMV and recombining 
into pADeasy-1. HEK293Ad cells were transfected with pAd-Track-CMV and 
the recombined plasmid. Adenovirus was collected from freeze-thawing 
transfected cells then amplified by infecting monolayers of 293Ad cells in 
T75 tissue culture flasks (Baumgartner et al., 2006).
Immunoblotting, immunolabeling, and immunoprecipitation
Immunoblotting was performed by lysing cells in ice-cold Nonidet P-40 
lysis buffer, collecting postnuclear supernatants, and separating 40 µg of 
protein by SDS-PAGE. Proteins were transferred onto PVDF membranes, 
blocked in 5% BSA, and probed with primary antibodies for 60 min. 
We used antibodies for a mouse monoclonal V5 (1:5,000; Life Technolo-
gies), mouse monoclonal HA (1:1,000; ABM), mouse monoclonal tubulin 
(1:2,000; Sigma-Aldrich), rabbit monoclonal ARPC2 (1:1,000; EMD Mil-
lipore), rabbit polyclonal ARPC1 (1:5,000, generated to the C terminus 
of ARPC1 [CKTLESSIQGLRIM] by OpenBiosystems; Thermo Fisher Scien-
tific), and rabbit polyclonal ZC1-3a for NIK (1:3,000; Baumgartner et al., 
2006). After washing, membranes were incubated with HRP-coupled 
secondary antibodies (1:5,000; Jackson ImmunoResearch Laboratories) 
for 1 h at room temperature, and immunoreactivity was visualized using 
enhanced femto chemiluminescence (Thermo Fisher Scientific) with reac-
tions imaged using a Chemidoc XRS (BioRad Laboratories).
For immunolabeling, cells were fixed for 10 min with 4% parafor-
maldehyde in PBS, washed with PBS, and permeabilized for 10 min with 
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In vitro kinase and binding assays
Kinase reactions were performed in kinase reaction buffer (25 mM Hepes, 
pH 7.5, 1 mM DTT, 10 mM MgCl2, 2 mM MnCl2, 50 mM nonradio-
active ATP, and 5 µCi [32P]-ATP) for 20 min at 30°C. Reactions con-
tained 200 ng NIK generated by baculovirus/insect cell expression, as 
described previously (Baumgartner et al., 2006). In brief, the NIK gene 
(NM_001252200) was ligated into pFASTBac and recombined into a 
bacmid genome in DH10BAC cells (Life Technologies). Bacmid encoding 
NIK was isolated and transfected into sf9 cells, and supernatants contain-
ing baculovirus were collected. Viral stocks were used to infect sf9 cells 
in suspension. Recombinant NIK was purified by nickel affinity chroma-
tography. Native Arp2/3 complex purified from A. castellanii was puri-
fied (provided by D. Mullins, University of California, San Francisco, San 
Francisco, CA), WT rArp2/3 complex was generated by baculovirus/ 
insect cell expression as described previously (Gournier et al., 2001), or 
rArp2/3 containing mutant Arp2-T237/238A-Y202A was generated as 
described previously (Narayanan et al., 2011). In brief, Sf21 cells were 
infected with baculoviruses containing cDNA encoding Arp2/3 complex 
subunits. Infected cells were grown in suspension for 48°C for 48 h. Re-
combinant Arp2/3 complexes were purified on Talon affinity resin (Takara 
Bio Inc.). Purified Arp2/3 complex was passed over a Superdex 200 FPLC 
column (GE Healthcare) to isolate fully assembled complexes. A range of 
Arp2/3 concentrations from 1 nM to 500 nM per reaction were performed 
to determine kinase kinetics. Reactions were stopped by the addition of 
Laemmli buffer, proteins were separated by SDS/PAGE, and gels were 
dried and exposed to x-ray film.
Binding assays were performed in binding buffer (50 mM Tris, pH 7.4, 
150 mM NaCl, 1 mM DTT, 100 µM ATP, 1% BSA, and 5% glycerol) 
containing rArp2/3 complex coupled to CH-Sepharose (GE Healthcare) 
and the indicated NIK truncations. Truncated NIK proteins were generated 
by in vitro expression using a cell-free expression kit (Life Technologies) 
with Express-Tag EXPRESS Protein Labeling Mix (PerkinElmer) containing 
[35S]methionine. Arp2/3-coupled Sepharose was incubated with the la-
beled protein for 30 min at 25°C. Sepharose was pelleted by centrifuga-
tion, washed with binding buffer, and analyzed by SDS-PAGE. Gels were 
dried and visualized to be detected by autoradiography.
The dissociation constant (Kd) of NIK 340–500 for Arp2/3 complex 
was determined by incubating glutathione-bound GST-NIK 340–500 with 
progressive dilutions of Arp2/3 complex in Arp2/3 binding buffer (2 mM 
Tris, pH 8.0, 0.2 mM ATP, 0.1 mM CaCl2, and 0.5 mM DTT) from 
2,000 ng/ml to 25 ng/ml for 30 min at 37°C. Sepharose-bound protein 
complexes were centrifuged at 3,000 g, resuspended in Laemmli buffer, 
and separated by SDS-PAGE. Gels were stained in Coomassie brilliant 
blue, imaged on an Odyssey Li-Cor scanner, and quantified using ImageJ. 
Protein binding curves were generated using GraphPad Prism.
Online supplemental material
Fig. S1 shows that the expression of Arp2/3-TTY slows the grow rate of 
MTLn3 cells. Fig. S2 shows Arp2/3 complex phosphorylation and bind-
ing. Fig. S3 shows that NIK regulates the Arp2/3 actin nucleation rate and 
membrane protrusion. Online supplemental material is available at http://
www.jcb.org/cgi/content/full/jcb.201404095/DC1.
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